van der Heiden P - Search Results

1

Control of Cytomegalovirus Viremia after Allogeneic Stem Cell Transplantation: A Review on CMV-Specific T Cell Reconstitution.

van der Heiden P, Marijt E, Falkenburg F, Jedema I. van der Heiden P, et al. Biol Blood Marrow Transplant. 2018 Sep;24(9):1776-1782. doi: 10.1016/j.bbmt.2018.03.028. Epub 2018 Apr 4. Biol Blood Marrow Transplant. 2018. PMID: 29626514 Free article. Review.

2

Efficacy and toxicity of gemtuzumab ozogamicin in patients with acute myeloid leukemia.

van der Heiden PL, Jedema I, Willemze R, Barge RM. van der Heiden PL, et al. Eur J Haematol. 2006 May;76(5):409-13. doi: 10.1111/j.1600-0609.2005.00623.x. Epub 2006 Feb 15. Eur J Haematol. 2006. PMID: 16480432

3

Oral valganciclovir as pre-emptive therapy has similar efficacy on cytomegalovirus DNA load reduction as intravenous ganciclovir in allogeneic stem cell transplantation recipients.

van der Heiden PL, Kalpoe JS, Barge RM, Willemze R, Kroes AC, Schippers EF. van der Heiden PL, et al. Bone Marrow Transplant. 2006 Apr;37(7):693-8. doi: 10.1038/sj.bmt.1705311. Bone Marrow Transplant. 2006. PMID: 16501590

4

Assessment of disseminated adenovirus infections using quantitative plasma PCR in adult allogeneic stem cell transplant recipients receiving reduced intensity or myeloablative conditioning.

Kalpoe JS, van der Heiden PL, Barge RM, Houtzager S, Lankester AC, van Tol MJ, Kroes AC. Kalpoe JS, et al. Eur J Haematol. 2007 Apr;78(4):314-21. doi: 10.1111/j.1600-0609.2007.00821.x. Epub 2007 Feb 27. Eur J Haematol. 2007. PMID: 17331130

5

Comparable incidence and severity of cytomegalovirus infections following T cell-depleted allogeneic stem cell transplantation preceded by reduced intensity or myeloablative conditioning.

Kalpoe JS, van der Heiden PL, Vaessen N, Claas EC, Barge RM, Kroes AC. Kalpoe JS, et al. Among authors: van der heiden pl. Bone Marrow Transplant. 2007 Jul;40(2):137-43. doi: 10.1038/sj.bmt.1705701. Epub 2007 May 28. Bone Marrow Transplant. 2007. PMID: 17530007

6

Identification of varicella-zoster virus-specific CD8 T cells in patients after T-cell-depleted allogeneic stem cell transplantation.

van der Heiden PL, de Boer R, van der Steen DM, Kester MG, van der Hoorn MW, Haarman WM, Barnby-Porritt HE, Fry JW, Napper CE, Marijt EW, Willemze R, Falkenburg JH, Heemskerk MH. van der Heiden PL, et al. J Virol. 2009 Jul;83(14):7361-4. doi: 10.1128/JVI.02662-08. Epub 2009 Apr 22. J Virol. 2009. PMID: 19386715 Free PMC article.

7

Mass spectrometry-based comparative sequencing to detect ganciclovir resistance in the UL97 gene of human cytomegalovirus.

Posthuma CC, van der Beek MT, van der Blij-de Brouwer CS, van der Heiden PL, Marijt EW, Spaan WJ, Claas EC, Nederstigt C, Vossen AC, Snijder EJ, Kroes AC. Posthuma CC, et al. J Clin Virol. 2011 May;51(1):25-30. doi: 10.1016/j.jcv.2011.01.015. Epub 2011 Mar 8. J Clin Virol. 2011. PMID: 21388868

8

Influence of polymorphisms in innate immunity genes on susceptibility to invasive aspergillosis after stem cell transplantation.

de Boer MG, Jolink H, Halkes CJ, van der Heiden PL, Kremer D, Falkenburg JH, van de Vosse E, van Dissel JT. de Boer MG, et al. PLoS One. 2011 Apr 4;6(4):e18403. doi: 10.1371/journal.pone.0018403. PLoS One. 2011. PMID: 21483748 Free PMC article.

9

Effective treatment of refractory CMV reactivation after allogeneic stem cell transplantation with in vitro-generated CMV pp65-specific CD8+ T-cell lines.

Meij P, Jedema I, Zandvliet ML, van der Heiden PL, van de Meent M, van Egmond HM, van Liempt E, Hoogstraten C, Kruithof S, Veld S, Marijt EW, von dem Borne PA, Lankester AC, Halkes CJ, Falkenburg JH. Meij P, et al. Among authors: van egmond hm, van der heiden pl, van liempt e, van de meent m. J Immunother. 2012 Oct;35(8):621-8. doi: 10.1097/CJI.0b013e31826e35f6. J Immunother. 2012. PMID: 22996368 Clinical Trial.

10

CMV seronegative donors: Effect on clinical severity of CMV infection and reconstitution of CMV-specific immunity.

van der Heiden PLJ, van Egmond HM, Veld SAJ, van de Meent M, Eefting M, de Wreede LC, Halkes CJM, Falkenburg JHF, Marijt WAF, Jedema I. van der Heiden PLJ, et al. Among authors: van egmond hm, van de meent m. Transpl Immunol. 2018 Aug;49:54-58. doi: 10.1016/j.trim.2018.04.003. Epub 2018 Apr 18. Transpl Immunol. 2018. PMID: 29679650

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

43 results

Search Page